Try a new search

Format these results:

Searched for:

in-biosketch:true

person:silkm01

Total Results:

24


The state of irreversible electroporation in interventional oncology

Silk, Mikhail; Tahour, David; Srimathveeravalli, Govindarajan; Solomon, Stephen B; Thornton, Raymond H
A new ablation modality, irreversible electroporation (IRE), has been of increasing interest in interventional radiology. Its nonthermal mechanism of action of killing tumor cells allows physicians the ability to ablate tumors in areas previously contraindicated for thermal ablation. This article reviews the current published clinical outcomes, imaging follow-up, and the current knowledge gaps in the procedure for patients treated with IRE.
PMCID:4078112
PMID: 25053862
ISSN: 0739-9529
CID: 5333352

Percutaneous ablation of peribiliary tumors with irreversible electroporation

Silk, Mikhail T; Wimmer, Thomas; Lee, Kyungmouk S; Srimathveeravalli, Govindarajan; Brown, Karren T; Kingham, Peter T; Fong, Yuman; Durack, Jeremy C; Sofocleous, Constantinos T; Solomon, Stephen B
PURPOSE/OBJECTIVE:To assess biliary complications after irreversible electroporation (IRE) ablation of hepatic tumors located < 1 cm from major bile ducts. MATERIALS AND METHODS/METHODS:A retrospective review was conducted of all percutaneous IRE ablations of hepatic tumors within 1 cm of the common, left, or right hepatic ducts at a single institution from January 2011 to September 2012. Computed tomography imaging performed before and after treatment was examined for evidence of bile duct dilatation, stricture, or leakage. Serum bilirubin and alkaline phosphatase levels were analyzed for evidence of biliary injury. RESULTS:There were 22 hepatic metastases in 11 patients with at least one tumor within 1 cm of the common, left, or right hepatic duct that were treated with IRE ablations in 15 sessions. Median tumor size treated was 3.0 cm (mean, 2.8 cm ± 1.2, range, 1.0-4.7 cm). Laboratory values obtained after IRE were considered abnormal after four treatment sessions in three patients (bilirubin, 2.6-17.6 mg/dL; alkaline phosphatase, 130-1,035 U/L); these abnormal values were transient in two sessions. Two patients had prolonged elevation of values, and one required stent placement; both of these conditions appeared to be secondary to tumor progression rather than bile duct injury. CONCLUSIONS:This clinical experience suggests that IRE may be a treatment option for centrally located liver tumors with margins adjacent to major bile ducts where thermal ablation techniques are contraindicated. Further studies with extended follow-up periods are necessary to establish the safety profile of IRE in this setting.
PMID: 24262034
ISSN: 1535-7732
CID: 5333342

REGIONAL GENETIC VARIABILITY DETECTED WITH RENAL TUMOR BIOPSIES: IMPLICATIONS IN BIOMARKER DEVELOPMENT [Meeting Abstract]

Sankin, Alexander; Mikkilineni, Nina; Hakimi, A. Ari; Silk, Mikhail; Liang, Yupu; Mano, Roy; Durack, Jeremy C.; Coleman, Jonathan; Russo, Paul; Hsieh, James
ISI:000350277901031
ISSN: 0022-5347
CID: 5333432

ORGN 777-Progress toward novel polycyclic aromatic hydrocarbons by corannulene oligomerization [Meeting Abstract]

Rose, Jonathan A.; Silk, Mikhail T.; Scott, Lawrence T.
ISI:000207594300424
ISSN: 0065-7727
CID: 5333422